Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver
出版年份 2016 全文链接
标题
Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver
作者
关键词
Resveratrol, NF-κB inflammation pathway, AMP-activated protein kinaseα, Sirtuin1
出版物
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 422, Issue 1-2, Pages 75-84
出版商
Springer Nature
发表日期
2016-09-09
DOI
10.1007/s11010-016-2807-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
- (2016) Sara Heebøll et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- SREBP-1c overactivates ROS-mediated hepatic NF-κB inflammatory pathway in dairy cows with fatty liver
- (2015) Xinwei Li et al. CELLULAR SIGNALLING
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- The Emerging Role of Sirtuin 1 in Cellular Metabolism, Diabetes Mellitus, Diabetic Kidney Disease and Hypertension
- (2015) A. Guclu et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- NEFAs activate the oxidative stress-mediated NF-κB signaling pathway to induce inflammatory response in calf hepatocytes
- (2015) Xiaoxia Shi et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway
- (2015) Yong Zhang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?
- (2014) Nanda Gruben et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Non-Esterified Fatty Acids Activate the AMP-Activated Protein Kinase Signaling Pathway to Regulate Lipid Metabolism in Bovine Hepatocytes
- (2013) Xinwei Li et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Maternal Hypoxia Increases the Susceptibility of Adult Rat Male Offspring to High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease
- (2013) Yi-Ming Su et al. ENDOCRINOLOGY
- Thermogenesis is involved in the body-fat lowering effects of resveratrol in rats
- (2013) Goiuri Alberdi et al. FOOD CHEMISTRY
- Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes
- (2013) Andreas L. Birkenfeld et al. HEPATOLOGY
- Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation
- (2013) João Marcus Oliveira Andrade et al. NUTRITION
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
- (2012) Nathan L. Price et al. Cell Metabolism
- Cidea promotes hepatic steatosis by sensing dietary fatty acids
- (2012) Linkang Zhou et al. HEPATOLOGY
- Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet
- (2012) Morten Møller Poulsen et al. NUTRITION RESEARCH
- NF-κB, Inflammation, and Metabolic Disease
- (2011) Rebecca G. Baker et al. Cell Metabolism
- Inflammatory links between obesity and metabolic disease
- (2011) Carey N. Lumeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice
- (2010) Susana Sánchez-Fidalgo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Resveratrol Improves Insulin Resistance Hyperglycemia and Hepatosteatosis But Not Hypertriglyceridemia, Inflammation, and Life Span in a Mouse Model for Werner Syndrome
- (2010) Adam Labbé et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice
- (2009) Zheng Shen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1–FOXO1 signaling pathway
- (2009) Guang-Li Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
- (2009) Carles Cantó et al. CURRENT OPINION IN LIPIDOLOGY
- Kupffer cells in non-alcoholic fatty liver disease: The emerging view
- (2009) György Baffy JOURNAL OF HEPATOLOGY
- SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
- (2008) Xiuyun Hou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet
- (2008) Jiyun Ahn et al. JOURNAL OF HEPATOLOGY
- Resveratrol addiction: To die or not to die
- (2008) Mehdi Shakibaei et al. MOLECULAR NUTRITION & FOOD RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started